Multiple coupling of human D5 dopamine receptors to guanine nucleotide binding proteins G(s) and G(z)

Journal of Neurochemistry

Volumn 70, Issue 6, 1998, Pages 2459-2467

  Sidhu, Anita ^a,c   Kimura, Kazuhiro ^a,d   Uh, Misook ^a   White, Beatrix H ^a   Patel, Shutish ^b  

^a GEORGETOWN UNIVERSITY   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^d HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Cholera toxin; Dopamine receptors; G proteins; Pertussis toxin; Signal transduction

Indexed keywords

ADENYLATE CYCLASE; CHOLERA TOXIN; DOPAMINE 1 RECEPTOR; DOPAMINE 5 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN GSALPHA; GUANINE NUCLEOTIDE BINDING PROTEIN GZ; N ETHYLMALEIMIDE; PERTUSSIS TOXIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BINDING SITE; COMPLEX FORMATION; CONTROLLED STUDY; IMMUNOPRECIPITATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RAT; RECEPTOR BINDING; RECEPTOR SOLUBILIZATION; RECEPTOR UPREGULATION;

ANIMALIA;

EID: 0031746740     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.70062459.x     Document Type: Article

References (48)

1. q/11. J. Biol. Chem. 269, 13733-13735.
2. Bergson C, Mrzljok L., Lidow M. S., Goldman-Rakic P. S., and Levenson R. (1995) Characterization of subtype-specific antibodies to the human D5 dopamine receptor: studies in primate brain and transfected mammalian cells. Proc. Natl. Acad. Sci. USA 92, 3468-3472.
3. Bertorello A. and Aperia A. (1988) Pertussis toxin modulates dopamine inhibition of Na,K-ATPase activity in rat proximal convoluted tubule segments. Prog. Clin. Biol. Res. 268, 353-356.
4. +-ATPase activity in neostriatal neurons through D1 and D2 receptor synergism. Nature 347, 386-388.
5. Birnbaumer L., Abramowitz J., and Brown A. M. (1990) Receptor-effector coupling by G proteins. Biochim. Biophys. Acta 1031, 163-224.
6. z, a guanine nucleotide-binding protein with unique biochemical properties. J. Biol. Chem. 265, 2383-2390.
7. Cooper D. M. F., Mons N., and Karpen J. W. (1995) Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 374, 421-424.
8. Dahmer M. K. and Senogles S. E. (1996) Dopaminergic inhibition of catecholamine secretion from chromaffin cells: evidence that inhibition is mediated by D4 and D5 dopamine receptors. J. Neurochem. 66, 222-232.
9. Demchyshyn L. L., Sugamori K. S., Lee F. J. S., Hamadanizadeh S. A., and Niznik H. B. (1995) The dopamine D1D receptor: cloning and characteristics of three pharmacologically distinct D-1-like receptors from Gallus domesticus. J. Biol. Chem. 270, 4005-4012.
10. Felder C. C., Jose P. A., and Axelrod J. (1989) The dopamine-1 agonist, SKF 82526, stimulates phospholipase C activity independent of adenylate cyclase. J. Pharmacol. Exp. Ther. 248, 171-175.
11. Gilman A. G. (1987) G proteins: transducers of receptor-generated signals. Annu. Rev. Biochem. 56, 615-649.
12. Gingrich J. A. and Caron M. G. (1993) Recent advances in the molecular biology of dopamine receptors. Annu. Rev. Neurosci. 16, 299-321.
13. Glatt C. E. and Snyder S. H. (1993) Cloning and expression of an adenylyl cyclase localized to the corpus striatum. Nature 361, 536-538.
14. Grandy D. K., Zhang Y., Bouvier C., Zhou Q.-Y., Johnson R. A., Allen L., Buck K., Bunzow J. R., Salon J., and Civelli O. (1991) Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes. Proc. Natl. Acad. Sci. USA 88, 9175-9179.
15. Hepler J. R. and Gilman A. G. (1992) G proteins. Trends Biochem. Sci. 17, 383-387.
16. Hill P., Lai Y., Hnilo J., Lin C.-C., Karla M., Bounds S., Herz J., and Mitchell R. (1996) Cloning, expression and comparison of the binding characteristics of the known human dopamine receptors. Adv. Neurol. 69, 41-52.
17. z in rat liver. J. Biol. Chem. 269, 1845-1851.
18. Kimura K., Sela S., Bouvier C., Grandy D. K., and Sidhu A. (1995a) Differences in the binding properties of D-1 and D-5 dopamine receptors expressed in GH4C1 rat somatomammotrophic cells. J. Neurochem. 64, 2118-2124.
19. o. J. Biol. Chem. 270, 14672-14678.
20. z. J. Biol. Chem. 270, 1734-1741.
21. 2 adrenergic receptor subtypes and G proteins in reconstituted phospholipid vesicles. Biochemistry 30, 3335-3341.
22. 1 receptors independently of adenylyl cyclase activation. J. Neurochem. 61, 1461-1469.
23. Law S. F., Manning D. R., and Reisine T. (1991) Identification of the subunits of GTP-binding proteins coupled to somatostatin receptors. J. Biol. Chem. 266, 17885-17897.
24. zα by site-directed mutagenesis: sites and specificity of protein kinase C-dependent phosphorylation. J. Biol. Chem. 268, 3494-3498.
25. Lowry O. H., Rosebrough N. J., Fair A. L., and Randall R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193, 265-275.
26. 2+ mobilization in Xenopus oocytes. Proc. Natl. Acad. Sci. USA 87, 2196-2200.
27. Milligan G. (1993) Mechanisms of multifunctional signalling by G protein-linked receptors. Trends Pharmacol. Sci. 14, 239-244.
28. Munson P. and Rodbard D. (1980) LIGAND: a versatile computerized approach for characterization of ligand binding systems. Anal. Biochem. 107, 220-239.
29. Neer E. J. (1994) G proteins: critical control points for transmem-brane signals. Protein Sci. 3, 3-14.
30. O'Dowd B. F. (1993) Structures of dopamine receptors. J. Neurochem. 60, 804-816.
31. z? Mol. Cell. Endocrinol. 100, 71-74.
32. 2a-adrenergic receptor-GTP-binding complexes using GTP-binding protein selective antisera. J. Biol. Chem. 267, 14826-14831.
33. Paulssen R. H., Johansen P. W., Gordeladze I. O., Nymoen O., Paulssen E. J., and Gautvik K. M. (1994) Cell-specific expression and function of adenylyl cyclases in rat pituitary tumor cell lines Eur. J. Pharmacol. 222, 97-103.
34. Piomelli D., Pilon C., Giros B., Sokoloff P., Martes M.-P., and Schwartz J.-C. (1991) Dopamine activation of the arachidonic acid cascade as a basis for D1/D2 receptor synergism. Nature 353, 164-167.
35. Rhee S. G. and Choi K. D. (1992) Regulation of inositol phospholipid-specific phospholipase C isozymes. J. Biol. Chem. 267, 12393-12396.
36. Schneider H., Feyen J. H., and Suewen K. (1994) A C-terminally truncated human parathyroid hormone receptor is functional and activates multiple G proteins. FEBS Lett. 351, 281-285.
37. Sidhu A. (1988) Solubilization and reconstitution of the D-1 dopamine receptor: potentiation of the agonist high-affinity state of the receptor. Biochemistry 27, 8768-8776.
38. Sidhu A. (1990) A novel affinity purification of the D-1 dopamine receptors from rat striatum. J. Biol. Chem. 265, 10065-10072.
39. Sidhu A., Kassis S., Kebabian J., and Fishman P. H. (1986) Sulphydryl group(s) in the ligand binding sites of the D-1 dopamine receptor: specific protection by agonist and antagonist. Biochemistry 25, 6695-6701.
40. 1 dopamine receptors can interact with both stimulatory and inhibitory guanine nucleotide binding proteins. J. Neurochem. 57, 1445-1451.
41. Sidhu A., Kimura K., and Vachvanichsanong P. (1994) Induction of Gpp(NH)p-insensitive agonist high-affinity binding sites of D-1 dopamine receptors by B-mercaptoethanol. Biochemistry 33, 11246-11253.
42. Simon M. I., Strathmann M. P., and Gautam N. (1991) Diversity of G proteins in signal transduction. Science 252, 802-808.
43. Smrcka A. V., Hepler J. R., Brown K. O., and Sternweis P. C. (1991) Regulation of polyphosphoinositide-specific phospholipase C activity by purified Gq. Science 251, 804-807.
44. 1C dopamine receptors from Xenopus laevis. Proc. Natl. Acad. Sci. USA 91, 10536-10540.
45. Sunahara R. K., Guan H.-C., O'Dowd B. F., Seeman P., Laurier L. G., Ng G., George S. R., Torchia J., Van Tol H. H. M., and Niznik H. B. (1991) Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1. Nature 350, 614-619.
46. 1-like dopamine receptor that couples to activation of phosphoinositide metabolism in brain. J. Neurochem. 62, 2045-2048.
47. z-mediated hormonal inhibition of cyclic AMP accumulation. Science 255, 339-342.
48. Yoshimura M., Ikeda H., and Tabakoff B. (1996) Opioid receptors inhibit dopamine-stimulated activity of type V adenylyl cyclase and enhance dopamine-stimulated activity of type VII adenylyl cyclase. Mol. Pharmacol. 50, 43-51.